Capital Investment Advisors LLC Has $11.02 Million Stake in Cardinal Health, Inc. $CAH

Key Points

• Capital Investment Advisors LLC reduced its stake in Cardinal Health by 5.0%, holding 65,600 shares valued at approximately $11.02 million after selling 3,469 shares.
• Cardinal Health recently reported a quarterly earnings per share (EPS) of $2.08, exceeding analyst expectations, with revenue of $60.16 billion, slightly below estimates.
• The company has declared a quarterly dividend of $0.5107 per share, with an annualized yield of 1.3%, set to be paid on October 15th.

Capital Investment Advisors LLC trimmed its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 5.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 65,600 shares of the company's stock after selling 3,469 shares during the period. Capital Investment Advisors LLC's holdings in Cardinal Health were worth $11,021,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the stock. MassMutual Private Wealth & Trust FSB lifted its position in shares of Cardinal Health by 3.6% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 1,767 shares of the company's stock worth $297,000 after purchasing an additional 62 shares in the last quarter. Perigon Wealth Management LLC lifted its position in shares of Cardinal Health by 3.2% during the second quarter. Perigon Wealth Management LLC now owns 2,314 shares of the company's stock worth $389,000 after purchasing an additional 72 shares in the last quarter. Pinnacle Bancorp Inc. lifted its position in shares of Cardinal Health by 11.2% during the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company's stock worth $106,000 after purchasing an additional 77 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. lifted its position in shares of Cardinal Health by 7.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,074 shares of the company's stock worth $181,000 after purchasing an additional 79 shares in the last quarter. Finally, Applied Finance Capital Management LLC lifted its holdings in Cardinal Health by 1.4% in the first quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company's stock valued at $833,000 after buying an additional 85 shares during the period. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Up 0.7%

Cardinal Health stock opened at $154.79 on Tuesday. The firm's fifty day moving average is $152.12 and its 200 day moving average is $149.79. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44. The company has a market capitalization of $36.78 billion, a PE ratio of 24.00, a PEG ratio of 1.30 and a beta of 0.73.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, beating the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm's revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Argus set a $189.00 price objective on shares of Cardinal Health in a research note on Friday, August 22nd. Leerink Partners decreased their price objective on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a research note on Tuesday, August 12th. Robert W. Baird lifted their price objective on Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. Finally, Evercore ISI decreased their price objective on Cardinal Health from $200.00 to $190.00 and set an "outperform" rating for the company in a research note on Wednesday, August 13th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $165.93.

Insider Buying and Selling at Cardinal Health

In related news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares in the company, valued at $3,881,969.70. The trade was a 61.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Jason M. Hollar sold 107,705 shares of the firm's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.90, for a total value of $16,037,274.50. Following the transaction, the chief executive officer directly owned 235,901 shares of the company's stock, valued at $35,125,658.90. This represents a 31.35% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by corporate insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.